Jobs / United States / Obsidian Therapeutics INC

Obsidian Therapeutics INC

Director/Senior Director, Manufacturing Science and Technology (MSAT)

Bedford, MA (HYBRID) Posted 24 days ago

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

About Us … Obsidian Therapeutics is pioneering engineered cell and gene therapies to deliver transformative outcomes for patients. Obsidian’s programs apply our cytoDRiVE® technology in Cell and Gene therapy products to control expression of proteins for enhanced therapeutic efficacy and safety. Obsidian’s lead program is currently in clinical development for the treatment of patients with metastatic melanoma and non-small cell lung cancer. We’re proud of our diverse talented team and committed to cultivating an environment of inclusion where each person feels a strong sense of belonging and is supported to continuously learn and contribute their best work. Our Research team is based in the heart of Cambridge, MA, and Technical Operations team is based in our purpose built facility in Bedford, MA. Obsidianites enjoy a highly collaborative culture, competitive salary and benefits, and potential for ownership through stock options. Our Opportunity... We are looking for a highly motivated Director/Senior Director, MSAT , with a strong background in drug development (preferably autologous cell therapy). You’ll serve as the go-to technical leader for manufacturing operations, solving complex problems and translating data into actionable improvements, helping to drive the development of our first clinical stage autologous cell therapy program targeting solid tumors. You will lead end-to-end MSAT strategy and execution, ensuring seamless progression from late-stage development through PPQ and lifecycle management. As the primary technical anchor between Process Development, Manufacturing, Quality, and our external partners, you’ll ensure the manufacturing processes remain robust, compliant, and efficient; drive deviation investigations to root cause, monitor critical process parameters (CPPs) and critical quality attributes (CQAs), and perform data trending and statistical analysis. As a member of our Technical Operations team, you will be a vital part of a highly collaborative group working to unlock the promise of precision cell therapy for patients, starting with our lead program amsoki-cel (OBX-115), a novel engineered tumor-infiltrating lymphocyte (TIL) cell therapy that uses our proprietary cytoDRiVE® platform. This is a unique opportunity to be a valuable contributor in a well-funded clinical company with field-leading advisors, best-in-class partners, and an experienced team. This is a Hybrid role based out of our Bedford, MA location. You Will... Core responsibilities • Serve as the lead MSAT interface to CDMOs, providing technical oversight of clinical manufacturing to ensure consistent production , rapid troubleshooting, and accelerated release of cell therapy drug product, viral vector drug substance, and custom biologic ancillary material s for patients in ongoing trials. • Manage escalations through joint governance forums and collaborate with Process Development and External Manufacturing to align on technical decisions and execution. • Define and maintain CPPs, CQAs with CDMOs • Partner with Process Development and Analytical Development to define process characterization plans, comparability strategy, and lifecycle control approaches. • Define and implement a comprehensive control strategy ahead of PPQ to enable consistent process performance, assure product quality, and support a successful validation and regulatory outcome • Own and maintain the integrity of process monitoring databases (CPV, PPQ, and lot history), utilizing statistical tools to monitor process variability, analyze trends, detect shifts, quantify variation, identify signals requiring investigation, and drive data-based insights and decisions. • Lead manufacturing campaign review processes. • Define and lead PPQ strategy and execution,

Apply on employer site ↗